Cite Filings / REGN / 0001104659-20-070667
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEFA14A

Proxy Materials

REGENERON PHARMACEUTICALS, INC. · Filed 2020-06-08 · Acc 0001104659-20-070667

Documents 1

  • DEFA14A Proxy Materials , tm2022025d1_defa14a.htm

Around this filing

  • 2021-04-23 DEFA14A Proxy Materials
  • 2020-06-10 4 EVP Finance CFO sold 4,271 shares at an average $608.01 ($2,596,792)
  • 2020-06-10 SC 13G Amended Statement of Ownership
  • 2020-06-09 4 Director sold 10,838 shares at an average $592.95 ($6,426,362)
  • 2020-06-08 DEFA14A Proxy Materials
  • 2020-06-05 4 Director sold 2,559 shares at $600.00 ($1,535,400)
  • 2020-04-24 DEFA14A Proxy Materials

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2022025d1_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…